NxStage Medical, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
DHRDanaher Corp. 2.81%324.350.7%$870.21m
TMOThermo Fisher Scientific, Inc. 1.15%640.271.0%$816.29m
ABTAbbott Laboratories 0.74%126.000.8%$635.79m
MDTMedtronic Plc -2.95%111.070.6%$601.18m
ISRGIntuitive Surgical, Inc. -3.00%329.230.8%$437.89m
ALGNAlign Technology, Inc. -2.91%634.226.4%$375.28m
DXCMDexCom, Inc. -1.11%591.967.8%$368.03m
BDXBecton, Dickinson & Co. 0.36%245.351.0%$349.27m
BSXBoston Scientific Corp. -5.21%38.581.0%$326.42m
SYKStryker Corp. -4.52%243.611.3%$297.07m
EWEdwards Lifesciences Corp. -4.29%109.580.4%$249.19m
AAgilent Technologies, Inc. -0.34%152.451.6%$233.89m
ZBHZimmer Biomet Holdings, Inc. -3.47%125.751.7%$224.38m
IDXXIDEXX Laboratories, Inc. -2.40%607.523.8%$217.44m
BAXBaxter International, Inc. -1.71%76.291.8%$195.95m

Company Profile

NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. Its primary product includes the NxStage System One (the System One). NxStage operates in two segments: System One and In-Center. The Company markets the System One to hospitals for treatment of acute kidney failure and fluid overload. In addition to the System One, NxStage sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD). These products, which consist of Medisystems, include hemodialysis blood tubing sets, A.V. fistula needles and apheresis needles. The Company's blood tubing set products include the ReadySet High Performance Blood Tubing set (ReadySet), and the Streamline Airless Blood Tubing set (Streamline).